About Endosphere
Endosphere was a Healthcare company based in Columbus (United States) founded in 2006 by Kenneth Binmoeller. It provides a duodenal insertable implant for effective obesity treatment. It operates on a B2B model. Endosphere has raised $6.45 million across 3 funding rounds from investors including Broadline Capital, Glengary and North Coast Angel Fund. The company is recorded as dissolved. Its focus areas include Medical Devices, Obesity Treatment and Implants. Its competitors include EnteroMedics, Elira and Aspire Bariatrics; 3 of its 3 listed competitors have raised funding.
Company details
Endosphere, led by Kenneth Binmoeller as Founder, Chief Medical Officer, specializes in providing healthcare solutions, developing medical devices, obesity treatment, and implants. Provides a duodenal insertable implant for effective obesity treatment. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
- Headquarters Columbus, United States
- Founders Kenneth Binmoeller
- SectorsHealthcare
- Website ww25.endosphereinc.com
- Total Equity Funding$6.45M (USD)
in 3 rounds
- Latest Funding Round$2M (USD), Series B
Jun 2015
- InvestorsBroadline Capital
& 4 more
Funding Insights of Endosphere
Endosphere has successfully raised a total of $6.45M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.45M
- Total Rounds 3
- Last Round Series B — $2M
- First Round $1.31M
(Jan 2011)
- Investors Count 5
All 4 funding rounds of Endosphere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $2M | Series B | – | – | – |
| Apr 2012 | $3.15M | Series B | – | – | – |
| Jun 2011 | Series A | – | – | ||
| Jan 2011 | $1.31M | Series A | – | Broadline Capital, Glengary | – |
5 investors in total: 5 institutional.
Investors in Endosphere
Endosphere has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadline Capital, Glengary and North Coast Angel Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| broadlinecapital.com | ||||
| glengaryllc.com | ||||
Angel investing is facilitated for startups in Cincinnati. | qca.com | Cincinnati, United States | ||
Startup Studio building companies in the US & Europe and Angel Network for Ohio based companies | rev1ventures.com | Columbus, United States | ||
| northcoastangelfund.com |
Investor details for Endosphere
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Endosphere
1 people are tracked at Endosphere (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kenneth Binmoeller | Founder, Chief Medical Officer | Leadership |
Complete people profiles for Endosphere
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Endosphere
3 dated milestones of Endosphere across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Endosphere is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Series B, of $2.0M.
Competitors of Endosphere
Endosphere has 3 listed competitors in our database, 3 of them funded. They include EnteroMedics, Elira and Aspire Bariatrics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enteromedics.com | 2002 | Saint Paul, United States | $62.1M | 63 | Satiety induction through vagal nerve block | |
| elira.com | 2004 | St. Louis, United States | $8.63M | Wearable neurostimulation devices for appetite suppression are developed by Elira. | ||
| aspirebariatrics.com | 2004 | King Of Prussia, United States | $29.44M | 7 | Aspire Bariatrics is focused on weight loss solutions. |
Detailed competitors of Endosphere
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Obesity
3 companies that operate in the same segment as Endosphere (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Endosphere
Endosphere was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Endosphere is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Endosphere is a funded company, having raised a total of $6.45M across 3 funding rounds to date. The company's 1st funding round was a Series A of $1.31M, raised on Jan 2011.
Endosphere, led by Kenneth Binmoeller as Founder, Chief Medical Officer, specializes in providing healthcare solutions, developing medical devices, obesity treatment, and implants. Provides a duodenal insertable implant for effective obesity treatment. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Endosphere's top competitors include EnteroMedics, Elira and Aspire Bariatrics.
Endosphere has 5 investors. Key investors include Broadline Capital, Glengary, North Coast Angel Fund, Queen City Angels, and Rev1 Ventures.